Equities

Regen BioPharma Inc

Regen BioPharma Inc

Actions
  • Price (USD)0.723
  • Today's Change0.008 / 1.08%
  • Shares traded3.40k
  • 1 Year change-57.47%
  • Beta2.8046
Data delayed at least 15 minutes, as of Apr 30 2024 16:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. It is involved on mRNA and small molecule therapies for treating cancer and autoimmune disorders. It is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax, tCellVax, Dura-CAR, KimerApt), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate). HemaXellerate is a personalized cellular therapeutic product designed to stimulate blood production in patients. tCellVax is a cell-based immunotherapy that stimulates the patient’s immune system through gene silencing of NR2F6.

  • Revenue in USD (TTM)236.58k
  • Net income in USD-772.29k
  • Incorporated2012
  • Employees1.00
  • Location
    Regen BioPharma Inc4700 Spring Street, Suite 304LA MESA 91942United StatesUSA
  • Phone+1 (619) 722-5505
  • Fax+1 (619) 330-2328
  • Websitehttps://regenbiopharmainc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
60 Degrees Pharmaceuticals Inc253.57k-3.99m2.75m3.00------10.86-0.6657-0.66570.04560.83820.05590.96381.8384,523.34-84.00-------87.15---1,504.04--2.39-1.890.0321---50.40--35.51------
Twinlab Consolidated Holdings Inc13.62m-9.66m2.79m17.00------0.2045-0.0373-0.05290.0526-0.53660.91061.344.41801,000.00-64.61-60.53----36.8121.36-70.96-37.720.0157-0.0516-----20.87-28.58-20.28------
Veritas Farms Inc730.65k-6.15m2.79m17.00--13.76--3.81-0.1319-0.13190.01360.00130.08770.80647.8042,979.41-69.02-72.11-123.21-93.59-220.0924.07-787.27-177.790.1392-5.560.95---63.42-0.942723.68---52.93--
Novelstem International Corp12.00k-4.19m2.81m15.00------234.41-0.0893-0.08930.0003-0.04160.0053--2.00---171.11---188.15-------32,373.50-----9.822.20--0.00---446.84------
Clever Leaves Holdings Inc17.42m-19.80m2.84m296.00--0.1156--0.1632-12.57-11.3811.1114.020.4181.6911.0358,841.21-47.51-23.20-58.14-26.5537.64---113.66-207.521.63-3.700.0479--6.14--47.63------
Eloxx Pharmaceuticals Inc0.00-20.48m2.86m18.00---------9.06-9.060.00-6.530.00----0.00-124.43-115.27---155.33-----------16.69--------45.95---22.56--
Regen BioPharma Inc236.58k-772.29k2.94m1.00------12.44-0.3564-0.35640.0658-1.400.8248--3.29236,580.00-289.03-104.36---------350.41-275.00---1.48----0.441618.79-58.11------
Agile Therapeutics Inc19.59m-14.47m2.95m19.00------0.1504-9.84-9.849.11-5.511.604.415.791,031,158.00-118.12-94.24---142.6254.18---73.85-513.500.3269------80.02--43.08------
ENDRA Life Sciences Inc0.00-10.06m2.95m21.00--0.491-----1.93-1.930.000.54470.00----0.00-125.53-132.00-149.91-157.28------------0.005------23.67---19.46--
Kiromic Biopharma Inc0.00-24.99m2.98m31.00---------29.21-29.210.00-3.810.00----0.00-171.18-161.49---213.01-----------15.691.87-------35.90--177.42--
NovaBay Pharmaceuticals Inc14.73m-16.70m2.99m24.00--0.6834--0.2033-3.82-3.823.500.29511.162.1610.78613,583.30-75.81-61.51-114.10-83.8953.6159.99-65.46-86.470.9998--0.2555--2.243.32-2.66---15.46--
CanaQuest Medical Corp0.00-806.12k3.00m-----------0.0513-0.05130.00-0.03700.00-------1,084.38--------------------------57.42------
Phio Pharmaceuticals Corp0.00-10.83m3.10m8.00--0.3272-----6.40-6.400.002.060.00----0.00-97.63-71.92-116.38-84.15-------253,785.70----0.00------5.70--0.00--
Resonate Blends Inc16.47k-1.42m3.10m6.00------188.33-0.0178-0.01780.0002-0.02470.0237-------203.52-680.29-----593.02-78.88-8,597.33-12,895.26---0.46917.89---66.73-56.57-316.63------
AccuStem Sciences Inc0.00-2.05m3.13m3.00---------0.1807-0.18070.00-0.18610.00----0.00-382.02--------------------------45.26------
Data as of Apr 30 2024. Currency figures normalised to Regen BioPharma Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.